Philips reports lower imaging sales

Article

Other headlines:TomoTherapy changes Siemens supply agreementGE strikes PET deal with Brigham and Women’s Johnson joins InSite One

Philips reports lower imaging sales

Philips Healthcare escaped the first quarter with a scant 2% decline in revenues compared with the year-earlier period, a slight drop compared with double-digit declines in the company's consumer lifestyle and lighting divisions. The modest size of the drop was achieved largely on the coattails of gains in home healthcare and through sales in emerging markets overseas, especially in Central and Eastern Europe, the Middle East, and India. The company noted lower sales at Imaging Systems, Healthcare Informatics/Patient Monitoring, and Clinical Care Systems. Chief Executive Gerard Kleisterlee said the company's healthcare group is facing a very soft U.S. hospital market but will continue "to execute its strategy to further build leadership in Health and Well-being, maintaining investments in R&D, marketing, and small acquisitions."

TomoTherapy changes Siemens supply agreement

On April 10, 2009, TomoTherapy amended its manufacture and supply agreement with Siemens for the manufacture, purchase, and sale of linear accelerators and related components. The amendment, which itself took effect April 1, 2009, but extends retroactively to Oct. 8, 2008, cuts the maximum price that Siemens can charge TomoTherapy to repair out-of-warranty linear accelerator assemblies. The amendment also provides that if a linear accelerator assembly cannot be repaired, as determined by both Siemens and TomoTherapy, then Siemens will issue a specified credit for the scrap value of the material. It adds to the warranty provision that repaired out-of-warranty accelerator assemblies are warranted for 12 months from the date of delivery.

GE strikes PET deal with Brigham and Women's

GE Healthcare has signed a research agreement with Brigham and Women's Hospital to transition PET developments into clinical applications. Staff from GE and the 777-bed teaching affiliate of Harvard Medical School plan to focus on developing personalized approaches to the diagnosis and management of patients with oncologic, neurologic, and cardiovascular diseases.

Johnson joins InSite One

Douglas L. Johnson has joined InSite One as director of enterprise storage solutions. Johnson, who has 30 years' experience in sales and marketing, will focus on integrated delivery networks and large hospitals whose requirements are addressed by InSite One's InDex enterprise archive and storage consolidation technologies.

Recent Videos
Study: MRI-Based AI Enhances Detection of Seminal Vesicle Invasion in Prostate Cancer
What New Research Reveals About the Impact of AI and DBT Screening: An Interview with Manisha Bahl, MD
Can AI Assessment of Longitudinal MRI Scans Improve Prediction for Pediatric Glioma Recurrence?
A Closer Look at MRI-Guided Adaptive Radiotherapy for Monitoring and Treating Glioblastomas
Incorporating CT Colonography into Radiology Practice
What New Research Reveals About Computed Tomography and Radiation-Induced Cancer Risk
What New Interventional Radiology Research Reveals About Treatment for Breast Cancer Liver Metastases
New Mammography Studies Assess Image-Based AI Risk Models and Breast Arterial Calcification Detection
Can Deep Learning Provide a CT-Less Alternative for Attenuation Compensation with SPECT MPI?
Employing AI in Detecting Subdural Hematomas on Head CTs: An Interview with Jeremy Heit, MD, PhD
Related Content
© 2025 MJH Life Sciences

All rights reserved.